Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: SciSparc Ltd.

Market Cap 4.25M 3.7M 3.43M 3.22M 6.02M 401M 6.06M 40.67M 15.75M 197M 15.94M 15.6M 685M P/E 2024
-0.33x
P/E 2025 -0.12x
Enterprise Value 22.73K 19.82K 18.33K 17.22K 32.19K 2.14M 32.43K 218K 84.31K 1.05M 85.31K 83.49K 3.67M EV / Sales 2024
-551,308x
EV / Sales 2025 289,759x
Free-Float
100%
Yield 2024 *
-
Yield 2025 -
1 day-7.84%
1 week-13.33%
Current month-24.46%
1 month+80.73%
3 months+60.04%
6 months-43.61%
Current year-39.46%
1 week 7.36
Extreme 7.355
8.71
1 month 4.1
Extreme 4.0951
15.79
Current year 2.98
Extreme 2.98
15.79
1 year 2.98
Extreme 2.98
80.1
3 years 2.98
Extreme 2.98
3,144.97
5 years 0.49
Extreme 0.4914
41,769.08
10 years 0.49
Extreme 0.4914
41,769.08
Manager TitleAgeSince
Chief Executive Officer 39 2022-01-09
Chief Executive Officer 62 2020-08-20
Chief Tech/Sci/R&D Officer 55 2016-02-07
Director TitleAgeSince
Chairman 62 2022-01-09
Chairman 78 2025-09-20
Director/Board Member 49 2020-08-20
Change 5-day change 1-year change 3-year change Capi.($)
-7.84%-13.33%-86.75%-99.72% 4.25M
+0.74%+1.69%+10.40%+85.32% 46.74B
-2.91%+3.09%+50.06%+90.35% 34.33B
-0.27%-2.71%-9.86%+33.69% 11.57B
-0.34%-3.07%+11.88%+92.57% 11.42B
-0.57%+0.96%+37.43%+128.26% 9.09B
+0.43%-1.68%+13.22%+41.07% 6.98B
+2.77%+1.83%+35.25%+243.81% 6.62B
-1.23%+1.65%+44.63%-18.54% 6.55B
+0.73%-2.94%-35.25%-2.32% 5B
Average -0.85%-1.97%+7.10%+59.45% 13.83B
Weighted average by Cap. -0.44%+0.99%+21.75%+82.93%

Financials

2024 2025
Net sales 1.31 1.14 1.05 0.99 1.85 123.17 1.86 12.5 4.84 60.53 4.9 4.8 210.66 0.86 0.75 0.69 0.65 1.21 80.73 1.22 8.2 3.17 39.68 3.21 3.14 138.08
Net income -6.28M -5.48M -5.07M -4.76M -8.9M -593M -8.96M -60.16M -23.31M -291M -23.59M -23.08M -1.01B -12.18M -10.62M -9.82M -9.23M -17.25M -1.15B -17.37M -117M -45.17M -564M -45.71M -44.73M -1.96B
Net Debt -2.01M -1.75M -1.62M -1.52M -2.85M -190M -2.87M -19.25M -7.46M -93.21M -7.55M -7.39M -324M -4.22M -3.68M -3.41M -3.2M -5.98M -398M -6.03M -40.45M -15.67M -196M -15.86M -15.52M -682M
Logo SciSparc Ltd.
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Employees
3
Date Price Change Volume
26-06-18 7.410 $ -7.84% 12,109
26-06-17 8.040 $ -0.12% 8,514
26-06-16 8.050 $ -3.48% 22,264
26-06-15 8.340 $ -2.46% 58,038

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SPRC Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!